[0001] The present invention relates in general to medical devices and procedures. More
specifically, the present invention relates to a kit for improving the intrauterine
environment prior to and during pregnancy.
BACKGROUND
[0002] Intrauterine insemination ("IUI") aims to place sperm into the reproductive system
of a patient to promote pregnancy. Typically, IUI is carried out for several reasons,
including cervical mucous problems, antisperm antibodies, low sperm concentration,
poor sperm mobility in the cervical canal, or simply to increase the number of viable
sperm in the uterine cavity. Currently, there are many tools that are utilized in
their individual capacity to increase the likelihood of a successful pregnancy using
IUI, but heretofore, those tools have not yet been combined in a logical manner to
maximize success.
[0003] Several clinical prerequisites exist prior to selecting IUI to treat infertility.
In general, before initiating an IUI cycle, the treating physician should order a
test, such as a hysterosalpingogram (HSG) or a sonohysterosalpingogram (Femvue), for
example, to confirm that at least one fallopian tube and the uterus are acceptable
for initiating a pregnancy in the female partner. The male partner should undergo
evaluation for the quality of the sperm source through semen analysis prior to selecting
IUI treatment. Both male and female partners should be appropriately screened for
infectious and genetic diseases prior to initiating an IUI cycle. Specific counseling
regarding risks of multiple pregnancy and cyst formation should be provided prior
to an initiating IUI cycle.
[0004] IUI may fail, at least in part, due to a harmful intrauterine environment that prevents
a fertilized egg from successfully implanting itself on the wall of the uterus. Accordingly,
a physician should utilize all available resources to improve the environment in the
uterus prior to insemination. In the past, physicians would intentionally scratch
the endometrium layer of the uterus to trigger an inflammatory response within the
uterine cavity prior to ovulation. The body's natural wound healing response following
the scratch improves the environment of the endometrium and makes it more likely for
an embryo to implant and create a pregnancy. Unfortunately, the commonly accepted
method for performing this procedure involves the physician blindly pushing the catheter
forward until he feels resistance; thereafter, believing he has reached the uterine
wall, he would haphazardly begin scratching. This random scratching of the uterine
wall is both uncontrolled and operator dependent, which can lead to increased rates
of complications such as uterine perforation or damage to the tubal ostia. A new device,
known as Accubrade
™, has since been developed to solve this problem, which is disclosed in the document
WO 2019/209775 A2. Unlike predecessor methods, the Accubrade
™ device is adapted for controlled insertion into the uterus and further includes a
trigger actuated articulating arm that will make a precise, small abrasion on the
endometrium wall while avoiding the risk of puncturing or penetrating the uterine
wall.
[0005] Additionally, for the best chances of a successful pregnancy, it is well known in
the art that insemination should take place during ovulation. Accordingly, there are
several devices in the art that are used to track ovulation for pregnancy purposes.
For example, the Priya Ring
™ is a device that monitors cervical temperature to predict the timing of ovulation.
Additionally, a physician may use ultrasound monitoring every few days following menstruation
to detect follicular development and measure endometrial thickness to project a woman's
"fertile window." Ovidrel
® may also be used to stimulate follicular release and force ovulation.
[0006] Another process that enhances pregnancy chances is to clean and prepare the sperm
for fertilization prior to insemination. Common sperm separation procedures, such
as the density gradient method, can require multiple rounds of centrifugation. This
practice is known to create sperm-damaging reactive oxygen species and DNA fragmentation,
which can affect the outcomes of artificial reproductive technology procedures. In
order to address these concerns, sperm separation devices that do not require centrifugation
have been developed in the art. A device known as ZyMot
™ is an example of such a device as described in the document
WO 2015/077333 A1. At a minimum, the ZyMot
™ device separates sperm based on motility within a microenvironment created by the
micropores in the filter. The device has an inlet port that communicates with the
lower sample chamber. The sample chamber is separated from the upper collection chamber
by a microporous filter. Untreated semen is added through the inlet port. After a
period of time, the separated sperm are collected from the upper chamber through the
outlet port. The purpose of ZyMot
™ is to separate the most viable, motile sperm in a sample through this gentle filtration
process, without iatrogenic damage of sperm and DNA fragmentation.
[0007] After the sperm are prepared, the next step is insemination where a semen sample
is deposited into a patient's uterine cavity. Generally, during such procedures, a
patient's vaginal walls are held open by a medical device, such as a speculum. A semen
sample is then inserted into the patient's cervical canal or uterine cavity, depending
on which procedure is being performed, typically via a catheter-syringe assembly.
After insertion, the semen is deposited into the patient's reproductive system.
[0008] However, a portion of the semen sample is often lost by leaking from the cervical
canal into the vaginal cavity of the patient due to reflux caused by uterine contractions.
Accordingly, unless a barrier is established between the patient's cervical canal
and vaginal cavity after the semen sample is inserted, the efficacy of the insemination
procedure may be diminished due to such reflux.
[0009] In order to prevent such reflux, a shielding device - for example, such as the one
described in the documents
WO 2018/101934 A1,
WO 2018/102590 A1 and
WO 2019/108818 A1 - is often deployed in order to serve as a cervical plug after insemination; the
device disclosed in these applications is known in the art as SEMSECURE
™. Such shielding devices vary in size and shape, but the general configuration consist
of some form of wall or barrier, with a bore usually in the center of the barrier.
[0010] An issue with plugs is that they may become dislodged when the catheter is removed.
A solution is the use of the catheter, where the catheter is then fed through the
bore of the shielding device and inserted into the cervical canal or uterine cavity
where a semen sample is directed through the catheter and deposited into the reproductive
system. After insemination, the shielding device serves as a barrier between the cervical
canal and the vaginal canal. The catheter is subsequently removed, however, the shielding
device is held in place by a holding device, such as the device known as SEMSUPPORT
™. Previously, these devices have not been sequenced and organized in a way to maximize
the likelihood of a successful pregnancy.
[0011] The document
US 6,511,415 B1 relates to an apparatus and a method useful for non-surgical embryo transfer or artificial
insemination of mammals. An apparatus for depositing media into the uterus of a mammal
includes a conical chamber that has a plurality of perforations and flaps. An exterior
spiral formation is configured for traversing or penetrating cervical passageway.
A sheath having a frusto-conical rearward end extends axially from an aft end of the
conical chamber. A tubular depositing chamber extends axially from the conical chamber
to a position beyond a fore end of the conical chamber. Coupled to the rearward end
of the depositing chamber is an embryo or semen packaging unit. The tubular depositing
chamber has an end that has an aperture to permit the flow of semen out of the depositing
chamber and into the uterus.
BRIEF SUMMARY OF THE INVENTION
[0012] Kits for use in performing an intrauterine insemination according to independent
claims are provided. Additionally, a method for intrauterine insemination and method
for performing a fertility procedure according to further independent claims are provided.
[0013] A method for intrauterine insemination is provided includes a step (a) of self-monitoring
of a menstrual cycle of a patient by the patient. Step (b) of the method makes an
abrasion on the endometrial lining of a uterus of the patient following menstruation
by the patient. Step (c) of the method (i) predicts timing of ovulation by using an
ovulation monitoring system or (ii) induces ovulation. Step (d) of the method prepares
sperm for insemination during ovulation by the patient. Step (e) of the method guides
an intrauterine insemination catheter accompanied by a cervical shield into the patient.
Step (f) of the method deposits a semen sample into the uterine cavity or cervical
canal. Step (g) of the method removes the catheter from the body of the patient while
using a holding tool to hold the cervical shield in place at the cervical os. Step
(h) of the method leaves the cervical shield in place for a predetermined time period.
[0014] In one embodiment, the abrasion in step (b) is made using AccubradeTM.
[0015] In another embodiment, the abrasion in step (b) is made during the pre-ovulatory
phase of the menstrual cycle. In one embodiment, the abrasion in step (b) is made
during days 7-10 of the menstrual cycle.
[0016] In yet another embodiment, the ovulation monitoring system in step (c) uses a Priya
RingTM.
[0017] In one, embodiment, the ovulatory response will be monitored with traditional urinary
LH surge testing.
[0018] In one embodiment, the ovulation monitoring system step (c) uses physician-controlled
ultrasound monitoring.
[0019] In another embodiment, the ovulation in step (c) is induced using Ovidrel
®
[0020] In yet another embodiment, the sperm for insemination step (d) is prepared using
ZyMotTM.
[0021] In one embodiment, the cervical shield in step (e) is SEMSECURETM.
[0022] In another embodiment, the holding tool in step (g) is SEMSUPPORTTM.
[0023] In yet another embodiment, the predetermined time period in step (h) is between twenty
minutes to two hours.
[0024] A method for intrauterine insemination may include a step (a) of self-monitoring
of a menstrual cycle of a patient by said patient. The method includes a step (b)
of making an abrasion on the endometrial lining of the uterus following menstruation
using AccubradeTM between days 7-10 of the menstrual cycle of the patient. The method
includes a step (c) of (i) predicting timing of ovulation using a Priya RingTM ovulation
monitoring system, physician-controlled ultrasound monitoring and/or (ii) inducing
ovulation using Ovidrel
®. The method includes a step (d) of preparing the sperm for insemination using ZyMotTM
during ovulation. The method includes a step (e) of guiding an intrauterine insemination
catheter accompanied by a SEMSECURETM cervical shield into the patient's reproductive
system. The method includes a step (f) of depositing a semen sample into the uterine
cavity or cervical canal. The method includes a step (g) of removing the catheter
from the body of the patient while using a SEMSUPPORTTM holding tool to hold the cervical
shield in place at the cervical os. The method includes a step (h) of leaving the
cervical shield in place for a period of twenty minutes to two hours.
[0025] A kit for use in performing an intrauterine insemination may include an abrasion
tool operable for making an abrasion on an endometrial lining of a uterus a patient,
an ovulation monitoring tool operable for predicting ovulation of the patient, a sperm
treatment tool operable for preparing sperm for insemination into the patient, an
intrauterine insemination catheter operable for inseminating the patient with sperm,
a cervical shield operable for preventing a semen sample from leaking from a cervical
canal into a vaginal cavity of the patient due to reflux caused by contractions of
the uterus, and a tool operable for holding the catheter and the cervical shield into
the patient.
[0026] In one embodiment, the abrasion tool in the kit is Accubrade
™.
[0027] In another embodiment, the ovulation monitoring tool in the kit is Priya Ring
™.
[0028] In yet another embodiment, the ovulation inducing tool in the kit is Ovidrel
®.
[0029] In one embodiment, the sperm treatment tool in the kit is ZyMot
™.
[0030] In another embodiment, the cervical shield in the kit is SEMSECURE
™.
[0031] In yet another embodiment, the holding tool in the kit is SEMSUPPORT
™.
[0032] A method for intrauterine insemination may comprise (a) self-monitoring of a menstrual
cycle of a patient by said patient; (b) a medical practitioner making an abrasion
on the endometrial lining of a uterus of the patient using an abrasion tool following
menstruation by the patient; (c) predicting timing of ovulation by using (i) an ovulation
monitoring system and/or (ii) inducing ovulation; (d) preparing sperm for insemination
during ovulation; (e) guiding an intrauterine insemination catheter accompanied by
a cervical shield into the patient; (f) depositing a semen sample into the uterine
cavity or cervical canal; (g) removing the catheter from the body of the patient while
using a holding tool to hold the cervical shield in place at the cervical os; and
(h) leaving the cervical shield in place for a predetermined time period.
[0033] The abrasion in step (b) may be made using AccubradeTM. The abrasion in step (b)
may be made during the pre-ovulatory phase of the menstrual cycle. The abrasion in
step (b) may be made between days 7-10 of the menstrual cycle.
[0034] The ovulation monitoring system in step (c) may use a Priya RingTM. The ovulation
monitoring system step (c) may use physician-controlled ultrasound monitoring. The
ovulation in step (c) may be induced using Ovidrel
®. The sperm for insemination step (d) may be prepared using ZyMotTM.
[0035] The cervical shield in step (e) may be SEMSECURETM. The holding tool in step (e)
may be SEMSUPPORTTM. The predetermined time period in step (g) may be at between twenty
minutes to two hours.
[0036] A set of prerequisite steps may be performed prior to step (a), the set of prerequisite
steps comprising: (i) a treating physician orders a test to confirm that at least
one fallopian tube and the uterus is acceptable for initiating a pregnancy in the
female partner; (ii) evaluation of the male partner for the quality of the sperm source
through semen analysis prior to selecting intrauterine insemination treatment; (iii)
screening the male and female partners for infectious and genetic diseases prior to
initiating an intrauterine insemination cycle; and (iv) physician counseling of the
male and female regarding risks of multiple pregnancy and cyst formation prior to
an initiating intrauterine insemination cycle. The testing in step (i) may be a hysterosalpingogram
(HSG). The testing in step (i) may be a sonohysterosalpingogram (Femvue).
[0037] A method for intrauterine insemination may comprise: a. self-monitoring of a menstrual
cycle of a patient by said patient; b. making an abrasion on the endometrial lining
of the uterus following menstruation using AccubradeTM during the pre-ovulatory phase
of the menstrual cycle; c. predicting timing of ovulation using (i) a Priya RingTM
ovulation monitoring system and/or physician-controlled ultrasound monitoring (ii)
or inducing ovulation using Ovidrel
®; d. preparing the sperm for insemination using ZyMotTM during ovulation; e. guiding
an intrauterine insemination catheter accompanied by a SEMSECURETM cervical shield
into the patient's reproductive system; f. depositing a semen sample into the uterine
cavity or cervical canal; g. removing the catheter from the body of the patient while
using a SEMSUPPORTTM holding tool to hold the cervical shield in place at the cervical
os; and h. leaving the cervical shield in place for a period of between twenty minutes
to two hours.
[0038] A kit for use in performing an intrauterine insemination may comprise: a sperm treatment
tool operable for preparing sperm for insemination into the patient; an intrauterine
insemination catheter operable for inseminating the patient with sperm; a syringe
operable to inject semen into the catheter; a cervical shield operable for preventing
a semen sample from leaking from a cervical canal into a vaginal cavity of the patient
due to reflux caused by contractions of the uterus; and a tool operable for holding
the catheter and the cervical shield into the patient.
[0039] The kit may comprise an abrasion tool operable for making an abrasion on an endometrial
lining of a uterus a patient. The kit may further comprise an ovulation monitoring
tool operable for predicting ovulation of the patient. The kit may comprise an ovulation
inducing tool operable for inducing ovulation in a patient.
[0040] The abrasion tool may be AccubradeTM. The ovulation monitoring tool may be Priya
RingTM. The ovulation inducing tool may be Ovidrel
®. The sperm treatment tool may be ZyMotTM. The cervical shield may be SEMSECURETM.
The holding tool may be SEMSUPPORTTM.
[0041] A kit for use in performing an intrauterine insemination may comprise: a sperm treatment
tool operable for preparing sperm for insemination into a patient; a cervical shield
operable for preventing a semen sample from leaking from a cervical canal into a vaginal
cavity of the patient due to reflux caused by contractions of the uterus; and a tool
operable for holding a catheter and the cervical shield into the patient.
[0042] A kit for use in performing an intrauterine insemination may comprise: an intrauterine
insemination catheter operable for inseminating a patient with sperm; a syringe operable
to inject semen into the catheter; a cervical shield operable for preventing a semen
sample from leaking from a cervical canal into a vaginal cavity of the patient due
to reflux caused by contractions of the uterus; and a tool operable for holding the
catheter and the cervical shield into the patient.
BRIEF DESCRIPTION OF THE DRAWINGS
[0043]
- FIG. 1
- is a flow diagram showing a preferred method for intrauterine insemination as disclosed.
- FIG. 2
- is a flow diagram showing a preferred method for intrauterine insemination as disclosed.
- FIG. 3
- is a flow diagram showing a preferred method for intrauterine insemination as disclosed.
- FIG 4
- illustrates an abrasion device in accordance with embodiments of the disclosed invention.
- FIG. 5
- is a profile view of an abrasion device showing the opposite side from that depicted
in FIG 4.
- FIG. 6
- is an exploded view of an abrasion device.
- FIG. 7
- is a topside view of the arm of an abrasion device.
- FIG. 8
- is a transparent perspective view of the connecting member of an abrasion device showing
the trigger mechanism.
- FIG. 9
- is a perspective view of an abrasion device showing the articulating tip in a curled
position.
- FIG. 10
- is a perspective view showing a holding tool.
- FIG. 11
- is a focused perspective view showing the distal end of a positioning tool.
- FIG. 12
- includes multiple perspective views of a cervical plug showing the valve in the closed
position.
- FIG. 13
- includes alternative views of a cervical plug with the valve in the open position.
- FIG. 14
- is a top view of a positioning tool and a cervical plug.
- FIG. 15
- is a perspective view of a positioning tool and a cervical plug with the syringe removed
from the catheter.
- FIG. 16
- is a focused perspective view of the kit shown in FIG. 15.
- FIG. 17
- is a front view of the kit shown in FIG. 15 wherein the shield of the cervical plug
is translucent.
- FIG. 18
- is a back view of the kit shown in FIG. 15.
- FIG. 19
- is a perspective view of the kit within a patient's reproductive system before the
positioning tool is inserted.
- FIG. 20
- is a perspective view of the system within a patient's reproductive system.
- FIG. 21
- is an illustration of an elastic vaginal ring with a temperature measurement and transmission
arrangement.
- FIG. 22
- is a plan view of a sperm sorting system.
- FIG. 23
- is a cross-sectional view of a sperm sorting system.
- FIG. 24
- is a schematic view of multichannel system with a collection chamber to concentrate
the sorted sperm.
DETAILED DESCRIPTION
[0044] Referring to the embodiment illustrated in
FIG. 1, a method
100 for intrauterine insemination is provided. The method
100 includes a step (a)
102 of self-monitoring of a menstrual cycle of a patient by the patient. Following the
completion of menstruation, which should occur on approximately day 6 of the cycle,
the patient will go to her physician, preferably between days 7-10 of her menstrual
cycle.
[0045] In an exemplary situation, a physician will make a precise, tiny abrasion on the
endometrial lining of the uterus in step (b)
104 of the method
100. The abrasion in step (b)
104 is preferably made between days 7-9 of the menstrual cycle but at very least a few
days prior to ovulation. The preferred device for performing the scratch is the Accubrade
™ device as described in the document
WO 2019/209775 A2. The Accubrade
™ device comprises a handle with a spring loaded trigger and an intravaginal/intracervical/intrauterine
arm with an articulating arm at its end that when actuated will move in a bidirectional
plane, approximately 4 mm in each direction to give a total moving arc and incision
of 1 cm (10 mm) along the endometrial lining of the uterus. The purpose of the device
and procedure is to incite an inflammatory reaction in the endometrial cavity which
has been shown in the literature to increase the pregnancy success rates of IUI by
as much as a factor of 2.0 to 2.3.
[0046] After the scratch is performed, the female patient will promptly begin monitoring
her reproductive system to predict ovulation. This can be done using a variety of
devices and methods known in the art. Step (c)
106 of the method
100 (i) predicts timing of ovulation by using an ovulation monitoring system and/or (ii)
inducing ovulation if ovulation has not started. The ovulation monitoring system in
step (c)
106 may be without the need of a physician, as the patient may use a device called Priya
Ring
™, or some other comparable device that utilizes circadian rhythm patterns known as
chronobiology to track a female patient's menstrual cycle and accurately predict when
ovulation will occur. When the Priya Ring
™ notifies the female patient that she is ovulating, IUI should take place within 24
hours. Alternatively, or in combination with the Priya Ring
™, a patient's physician may use ultrasound monitoring to detect follicular development
and measure endometrial thickness to predict ovulation. Generally, ovulation occurs
within days of a mature follicle developing. Preferred indicators for ovulation are
a mature follicle of 18mm or greater and a uterine stripe of 8mm or greater. If ovulation
has not started, the ovulation in step (c)
106 may be induced, at the patient's discretion, by injecting Ovidrel
® to stimulate follicular release. Preferably, the injection should take place 24-36
hours prior to IUI. Ovulation should generally occur within 7-10 days of the endometrial
abrasion, depending on the patient's menstrual cycle.
[0047] Based on the foregoing indicators of ovulation, the patient will promptly see her
physician, preferably within twenty-four hours, to undergo IUI while ovulating. At
the physician's office and prior to insemination, the sperm must be prepared for fertilization.
Step (d)
108 of the method
100 prepares sperm for insemination during ovulation by the patient. The preferred method
avoids using a well-known process known as centrifugation to separate sperm, as this
process damages the sperm and has led to negative outcomes. Sperm for insemination
step (d)
108 may be prepared using a device known in the art used to prepare motile sperm for
intrauterine insemination, such as ZyMot
™, for example. The ZyMot
™ device and method for separating sperm using said device is described in the document
WO 2015/077333 A1.
[0048] After the sperm are prepared, the physician will utilize a catheter to inseminate
the uterine cavity. Step (e)
110 of the method
100 guides an intrauterine insemination catheter accompanied by a cervical shield into
the patient. During the insertion process, the catheter in step (e)
110 may be is equipped with a cervical plug, such as the SEMSECURE
™ device described in the documents
WO 2018/101934 A1,
WO 2018/102590 A1 and
WO 2019/108818 A1. In general, the plugging device has a concave surface that sits flush with the cervix,
along with a graduated shaft with a bulb at its tip that secures itself within the
cervical canal. The device can come in multiple sizes to ensure an appropriate fit
and accommodate for anatomic variations between patients. The proximal portion (the
portion that lies outside of the cervical canal) is small enough that any cervical
anteversion or retroversion of the uterus will not dislodge the device. There is a
central lumen or bore within the middle of the device that allows for the passage
of an intrauterine catheter.
[0049] Step (f)
112 deposits a semen sample into the uterine cavity or cervical canal. Step (g)
114 of the method
100 removes the catheter from the body of the patient while using a positioning tool
to hold the cervical shield in place at the entrance to the uterine cavity. The positioning
tool (e.g. SEMSUPPORT
™) provides the opposing force against the cervical plug required to keep the plug
in place while the catheter is removed through the bore of the plug. Step (h)
116 of the method
100 leaves the cervical shield in place for a predetermined time period while acting
as a seal to the passageway from the uterine cavity into the cervical canal. The predetermined
time period in step (h)
116 may be between twenty minutes to two hours, for example.
[0050] Referring to
FIG. 2, a method
200 for intrauterine insemination is provided. The method includes a step (a)
202 of self-monitoring of a menstrual cycle of a patient by the patient. The method includes
a step (b)
204 of making an abrasion on the endometrial lining of the uterus following menstruation
using Accubrade
™ between days 7-9 of the menstrual cycle of the patient. The method includes a step
(c)
206 of predicting timing of ovulation using a Priya Ring
™ ovulation monitoring system, physician-controlled ultrasound monitoring or inducing
ovulation using Ovidrel
®. The method includes a step (d)
208 of preparing the sperm for insemination using ZyMot
™ during ovulation. The method includes a step (e)
210 of guiding an intrauterine insemination catheter accompanied by a SEMSECURE
™ cervical shield into the patient's reproductive system. The method includes a step
(f)
212 of depositing a semen sample into the uterine cavity or cervical canal. The method
includes a step (g)
214 of removing the catheter from the body of the patient while using a SEMSUPPORT
™ holding tool to hold the cervical shield in place at the cervical os. The method
includes a step (h)
216 of leaving the cervical shield in place for a period of twenty minutes to two hours.
[0051] For the purposes of this patent application, an exemplary kit is defined as comprising
an abrasion tool operable for making an abrasion on an endometrial lining of a uterus
a patient; an ovulation monitoring tool operable for predicting ovulation of the patient;
a sperm treatment tool operable for preparing sperm for insemination into the patient;
an intrauterine insemination catheter operable for inseminating the patient with sperm;
a cervical shield operable for preventing a semen sample from leaking from a cervical
canal into a vaginal cavity of the patient due to reflux caused by contractions of
the uterus; and a tool operable for holding the catheter and the cervical shield into
the patient.
[0052] In accordance with embodiments of the invention, a kit for use in performing an intrauterine
insemination is provided. The kit includes an abrasion tool
302 operable for making an abrasion on an endometrial lining of a uterus a patient, an
ovulation monitoring tool
800 operable for predicting ovulation of the patient, a sperm treatment tool
810 operable for preparing sperm for insemination into the patient, an intrauterine insemination
catheter
753 operable for inseminating the patient with sperm, a cervical shield
690 operable for preventing a semen sample from leaking from a cervical canal into a
vaginal cavity of the patient due to reflux caused by contractions of the uterus,
and a tool
605 operable for holding the catheter and the cervical shield while in the patient.
[0053] A method
400 of intrauterine insemination is disclosed in
FIG. 3. A patient's menstrual cycle begins in step
402. The menstruation concludes in step
404. In step
406, physician-controlled abrasion is performed on the endometrial lining of the patient's
uterus using Accubrade
™ or a similar abrasion device known in the art. In step
408, the patient self-monitors for ovulation using Priya RingTM or a similar ovulation
monitoring device known in the art. In step
410, which may coincide with step
408, a physician-controlled ultrasound monitoring occurs. In step
412, the patient ovulates or ovulates after stimulation using Ovidrel
®. Step
414 is an intrauterine insemination procedure at a physician's office. Step
414 includes step
416 of preparing sperm using Zymot
™, step
418 of performing insemination using a catheter with a cervical plug such as SEMSECURE
™, and step
420 of removing the catheter while leaving the plug in place using a holding device such
as SEMSUPPORT
™. The cervical plug remains in place in step
422.
[0054] Turning to
FIGS. 4-6, the preferred embodiment of the abrasion tool
302 is Accubrade
™, which comprises a handle
510, an arm
520 comprising an articulating tip
540, wherein the handle
510 is connected to the arm
520 by a connection member
550 that contains a spring-loaded trigger mechanism
560 operable to curl the articulating tip
540 in a variety of planar directions by pulling a trigger
565. Preferably, the handle
510 is offset approximately 45° from the longitudinal plane of the arm
520 to allow for easier guidance of the arm
520 into the uterine cavity, and said handle
510 is positioned such that the index finger (not shown) of the user can easily actuate
the trigger
565.
[0055] Turning to
FIG. 7, the articulating tip
540 at the distal end of the arm
520 is made from a material having flexible properties, including but not limited to,
flexible polymers, solid foam, thermoplastics, thermoset materials, or other materials
known in the art with similar properties. When activated the articulating tip
540 will curl in a given planar direction wherein the inner portion of the curled tip
540 will be compressed and the outer portion of the curled tip
540 will be in tension (as shown in
FIG. 9). Accordingly, it is preferable that the articulating tip
540 shall have larger circumferential slits
575 on the inner portion of the tip
540 and smaller circumferential slits
585 on the outer portion of the tip
540 to allow the articulating tip
540 to curl.
[0056] The proximal end of the arm comprises a rotatable knob
590 that is operable to adjust the planar direction of the articulating tip
540. The non-flexible portion
557, or rigid portion of the arm
520 positioned between the rotatable knob
590 and the articulating tip
540, is made from a substantially rigid material, e.g. metals or hardened polymers (e.g.
carbon fiber or other plastics), to prevent flexion along that portion
557 of the arm
520. For the preferred embodiment, the rotatable knob
590 comprises an indicator, e.g. an arrow
559, which alerts the user as to the planar direction the articulating tip
540 shall curl.
[0057] As shown in the figures, a cable or wire
561 extends longitudinally from the distal end of the arm
520 and wraps around the spring-loaded trigger mechanism
560 before returning to the distal end of the arm
520 such that a continuous closed loop is formed; a portion of the cable
561 is fixedly attached to the trigger mechanism
560 by a slot-pin
563 (as shown in detail in
FIG. 8) or some other attachment means known in the art. Alternatively, the invention anticipates
using at least two separate cables or wires
561 that follow a similar path and are in parallel, where one end of the wire is fixedly
attached to the trigger mechanism
560 and the opposite end of each wire
561 is fixedly attached at the distal end of the arm
520. For either arrangement, when the trigger
565 is actuated, the trigger mechanism
560 causes one portion of the cable
561 in the arm
520 to slack while the other portion is pulled in tension. This process enables the flexible
articulating tip
540 to curl in the direction that the cable
561 is being pulled, thus creating the annular curve
θ (as shown in Fig. 6). The degree of annular curve
θ created by the articulating tip
540 is directly proportionate to the degree the trigger
565 is pulled towards the handle
510. As shown in the figures, the exterior surface of the trigger mechanism
560 has an arrow
567, which will rotate in an opposite direction of the handle
510 when pulled. As a means to alert the user as to the degree of annular curve
θ, the arrow
567 will correspond to measurement markings on the exterior housing (not shown) of the
connecting member
550.
[0058] Turning to
FIGS. 6-7, the preferred embodiment further comprises a sleeve
569 that is adapted to fit over and fully enclose the arm
520; a cap portion
571 of the sleeve
569 covers the distal end of the articulating tip
540. The sleeve may be made from any fabric, polymer, or other material that is flexible
and has properties that will either minimize or not cause irritation to the patient.
As shown in
FIG. 7, the preferred embodiment of the cap portion
571 comprises a rounded surface to further minimize irritation to the patient when in
contact with the endometrium layer of the uterus. Although this embodiment is preferred,
it is envisioned that the cap portion
571 may come in different sizes, shapes, and materials depending on the needs of the
user.
[0059] As shown in
FIG. 6, the exterior surface of the sleeve
569 may contain measurement markings
573 that operate to inform the physician of the length of the arm
520 that has been inserted into the patient. Although not required, it is preferred that
these markings be spaced apart in one-centimeter increments.
[0060] The subject device is to be deployed inside the uterus in order to perform a small,
precise abrasion along the endometrium layer of the uterus. For optimal results, the
procedure will take place in the days leading up to ovulation; often, this occurs
on day 7, 8, or 9 of a menstrual cycle, depending on the patient. Using the handle
510, the physician shall guide the arm
520 through the cervix and into the uterine cavity of the patient until the cap portion
571 of the articulating tip
540 abuts the endometrial lining of the uterus. Next, when the trigger mechanism
560 is actuated by pulling the trigger
565 a distance inward toward the handle
510, the articulating tip
540 will curl in the planar direction as set by the rotating knob
590 and at an angular distance
θ proportionate to the degree the trigger
565 is pulled. The articulating tip
540 will create a small abrasion on the lining of the uterus. After the abrasion is made,
when the handle
510 is slowly released, the spring-loaded trigger mechanism
560 operates to bring the articulating tip
540 back to its resting state, which is a state of longitudinal alignment with the rigid
portion
557 of the arm
520. At this stage, the arm
520 can be safely and easily manually removed from the uterine cavity by the physician.
[0061] Turning to
FIG. 10, a perspective view of the preferred positioning tool
605, SEMSUPPORT
™, is shown. The tool
605 generally comprises a handle
610 on one end having a proximal end
615 and a distal end
620, a stem
630 extending longitudinally therefrom and connecting to a bracket
640 at the other end of the tool
605. It is anticipated that the stem
630 can be manipulated to be curved as shown in
FIG. 10, or alternatively, may take on other alignments, including but not limited to, a linear
alignment. It is envisioned that the positioning tool
605, including the handle
610, stem
630, and bracket
640 are made from a rigid or semi-rigid material (e.g. medical-grade silicone rubber,
metal, plastic, glass); however, any part thereof or the entire tool
605 may be made from a flexible material to better assist in the guiding and placement
of the tool
605 within the patient's reproductive system. Turning to
FIG. 11, the bracket
640 structurally comprises a bottom segment
650 that extends a general horizontal direction with two opposing and spaced apart segments
660 that originate at the bottom segment
650 and extend in a general vertical direction therefrom such the interior of the bracket
is accessible through the opening
670 between the opposing segments
660. It is anticipated that the two opposing segments may be linear or curvilinear.
[0062] Turning to
FIG. 12, the preferred embodiment for the preferred cervical plug
680, SEM-SECURE
™, is shown. The cervical plug
680 comprises a shield
690 having a first surface
700 and opposing second surface
710. As shown in the figure, the first surface
700 is preferably concave, but may be any shape to operably cover the cervical os
705 of a patient (as shown in
FIGS. 19-20). Alternatively, the shield
690 may be of another shape suitable for covering the cervical os
705 of a patient, such as an elliptical shape. The shield
690 may be shaped and sized such that the shield
690 can cover the cervical os
705 of nulliparous, primiparous, or multiparous women. To minimize pain or discomfort
experienced by a patient as the cervical plug
680 is inserted or removed from the patient's body, the shield
690 may be made of a material that is somewhat flexible such that the material may be
deformed by pressure applied by a user of the device but return to its original shape
when the pressure is removed. Alternatively, the shield
690 may be made of a material that is substantially rigid or semi-rigid. In addition,
the shield
690 may be made of a material that is at least partially translucent or transparent,
which may aid a user in inserting the device in the cervical canal.
[0063] Alternatively, the shield
690 may be made of an opaque material. The shield
90 may comprise medical-grade silicone rubber. Alternatively, the shield
690 may be made of any suitable material including, but not limited to, plastic, glass,
ceramic, metal, any type of rubber, or any combination thereof.
[0064] The cervical plug
680 further comprises an arm
720 that attaches to the first surface
700 of the shield
690 at the arm's
720 proximal end
730; the distal end
740 of the arm
720 is operable to extend into the cervical os of a patient and may be conically shaped
or substantially cylindrically shaped to ease discomfort caused by the insertion of
the arm
720 into the patient. The arm
720 is sufficiently rigid for inserting the arm
720 into the cervical canal
759 of a patient (as shown in
FIGS. 19-20), but the arm
720 may have some amount of flexibility in order to minimize pain or discomfort experienced
by the patient as the cervical plug
680 is inserted or removed. Alternatively, the arm
720 may be made of a material that is substantially rigid. In addition, the arm
720 may be made of a material that is at least partially translucent or transparent.
Alternatively, the arm
720 may be made of an opaque material. The arm
720 may comprise medical-grade silicone rubber. However, the arm may be made of any suitable
material including, but not limited to, plastic, glass, ceramic, metal, any type of
rubber, or any combination thereof.
[0065] The arm
720 may have a circumferential bulge
745 to help keep the cervical plug
680 in place with the arm
720 inserted into the cervical canal
759 during use. The bulge
745 is positioned along a length of the arm
720, preferably midway between the proximal end
730 and the distal end
740). Once the arm
720 is inserted into the cervical canal
759, as shown in
FIGS. 19-20, the wider diameter of the circumferential bulge
745 provides resistance to removal of the arm
720 from the cervical canal
759, thereby helping to keep the cervical plug
680 in place for a period of time after semen has been introduced into the cervical canal
759 or uterine cavity
761 so that the plug 680 prevents leakage of semen from the cervical canal
759 into the vaginal canal
757. The bulge
745 preferably comprises a contoured surface to prevent discomfort, however, this patent
envisions the bulge
745 having other configurations operable to prevent the cervical plug
680 from becoming dislodged.
[0066] The arm
720 may be permanently secured to the shield
680. For instance, the arm
720 and shield
690 may be molded as a unitary piece of material. Alternatively, the arm
720 may be secured to the shield
690 with an adhesive. A bore extends longitudinally through the center of the cervical
plug
680 with one opening at the proximal end
770 of the insert member
715 and another opening at the distal end
740 of the arm
720; the bore is operable to receive a catheter along the directionally dashed line
A through the cervical plug
680.
[0067] Turning to
FIGS. 12 and
13, the distal end
740 of the arm
720 is shown with an optional valve
790 that is operable between an open position (as shown in
FIG. 13) and the closed position (as shown in
FIG. 12). The valve
790 further comprises elastomeric flaps
751 integrally attached to the distal end
740 of the arm
720. These elastomeric flaps
751 are resiliently biased against each other when the valve is in the closed position
(as shown in
FIG. 12), such that they are operable to form a substantially fluid-tight seal over the opening
at the distal end
740 of the arm
720.
[0068] The opposing second surface
710 of the shield
690 is attached to an insert member
715 at the distal end
760 of the insert member
715 and provides a protrusion. The insert member
715 may function as an aid for inserting and removing the cervical plug
680 from the cervical canal
759. The insert member
715 may be permanently secured to the shield
690. For instance, the cervical plug
680 may be molded as a unitary piece of material including the shield
690, arm
720, and insert member
715. Alternatively, the insert member
715 may be secured to the shield
690 with an adhesive. As illustrated in
FIGS. 12-13 the insert member
715 may be secured to the shield
690 such that the insert member
715 forms a generally straight line with the arm
720. The insert member
715 may be made of a material that is at least partially translucent or transparent.
Alternatively, the insert member
715 may be made of an opaque material. The insert member
715 may comprise medical-grade silicone rubber. Alternatively, the insert member
715 may be made of any suitable material including, but not limited to, plastic, glass,
ceramic, metal, any type of rubber, or any combination thereof.
[0069] To facilitate removal of the cervical plug
680 after use, the insert member
715 may optionally have a string
755 attached thereto, as best seen in
FIG. 13. The string
755 attaches to the cervical plug
680 via tying means through an annular cavity in the insert member
715, or alternatively, may be permanently affixed through molding means to the insert
member
715. The string
755 may be a medical-grade suture, though any suitable material may be utilized. The
string
755 may be of a sufficient length to extend through the vaginal canal
757 and outside of the patient's body when the cervical plug
680 is inserted in the cervical canal
753, as seen in
FIGS. 19-20. By pulling the string
755, the cervical plug
680 may be removed through the vaginal canal
757 without forceps or a similar device.
[0070] As shown in
FIG. 14, a portion of the disclosed kit comprising the positioning tool
605, catheter
753, and cervical plug
680 is shown. As described more fully below, the catheter will be attached to a syringe
757 or some other device operable for injecting a semen deposit sample.
FIGS. 15-18 closely demonstrate how the bracket
640 of the positioning tool
605 is operable to receive the insert member
715 and engage the second surface
710 of the shield
690 without interfering with the catheter
753 extending from the opening
785 at the proximal end
770 of the insert member
715.
[0071] An internal personal fertility sensor
800 is operable to identify the subtle temperature changes that occur prior to ovulation.
One such device
800 for use in monitoring the ovulation of the patient is a Priya Ring
™, an elastic vaginal ring temperature sensing device that can comprise an elastic
ring structure and incorporated wireless transmitting arrangement
802, as illustrated in
FIG. 21 and disclosed in
US 8,715,204 B2. Cross section
803 illustrates the temperature sensing and transmission arrangement
802 can further comprise a transducer device, such as a temperature sensor, and a microcontroller,
memory and wireless transmitter. Such an arrangement can incorporate a passive (battery
free), battery assisted or active battery powered Radio Frequency Identification (RFID)
transponder circuit with temperature measurement capability. The temperature sensing
and transmission device comprises an antenna portion and electronic portion (e.g.,
RFID integrated circuit and other components), linked to a temperature sensing portion
that can sense the surrounding temperature. The elastic ring structure can be forced
in a spring-loaded state when elastically deformed thus becoming retained when disposed
in a vaginal vault. In one embodiment, an active RF receiver or an RFID reader is
brought in proximity to the temperature sensing and transmitting device arrangement,
such as near a woman's pelvis from the outside to read the temperature and record
it in a Central Processing Unit, CPU, associated with the receiver or RFID reader,
such as a portable, handheld computer.
[0072] The treatment tool
810 for preparing sperm for insemination is a passive method and apparatus for filtering
motile sperm from a sperm sample. The treatment tool
810 passively filters the motile sperm using a nucleopore membrane that is contained
within a membrane assembly, wherein the membrane assembly is disposed in a container.
In operation, a medium is placed in the container so the membrane contacts the medium.
A sperm sample is placed one side of the membrane assembly, and the motile sperm migrate
through the membrane leaving the non-motile sperm behind, where they can be easily
extracted.
[0073] One such treatment tool
810 operable for preparing sperm for insemination into a patient is the ZyMot
™, a treatment and method that integrates micro- and macro-fluidics to sort sperm in
a manner that allows efficient selection of sperm that are favorably suited to fertilization,
as illustrated in
FIGS. 22-24, and disclosed in
US 10,422,273 B2. In particular, the system recognizes that sperm suited to fertilization is most
desirable and can be selected or sorted using a system presents and environment that
is akin to that presented in the fertilization process. In this regard, the system
is provided where macro reservoirs are connected by micropores to approximate the
female genital track. The most motile, morphologically normal, mature, and functional
sperm pass selectively through the micropores against gravity leaving behind dead
or less functional sperm. The system is a chemical-free, centrifugation-free, and
flow-free technology, where functional sperm are isolated from unprocessed semen sample
with high retrieval rate.
[0074] Referring to
FIG. 22, the system
810 includes a housing
812 having an inlet
814 and a collection chamber
816 having a filter
818 arranged therein. The filter
818 may be a polycarbonate filter or other filter having suitable materials properties,
such as pore or passage size, as will be described. Referring to
FIG. 23, the inlet
814 and collection chamber
816 are connected through a passage or flow path
820 extending along a microfluidic chip
822. As will be described, the microfluidic chip
822 may include a microchip that may be disposable and that handles unprocessed semen
samples (either fresh or frozen, processed or raw), for example of 10µl to 3ml, and
sorts sperm rapidly, such as in less than 30 minutes, without the need for complex
instrumentation or trained operators.
[0075] The flow path
820 extends from the inlet
814 to the collection chamber
816. At the collection chamber
816 a first or bottom chamber
824 is located proximate to the microfluidic chip
822 and a second or top chamber
826 is located distally with respect to the microfluidic chip
822, above the first or bottom chamber
824. As will be described, the first chamber
824 is designed to collect the semen of a sample, whether fresh or frozen, processed
or raw, presented to the inlet
814 and the second chamber
826 is designed to filter the motile sperms.
[0076] Referring to
FIG. 24, the system
810 described above with respect to
FIG. 22 may be modified to include an additional collection or concentration chamber
825 that is connected to the top chamber by a fluid connection
827. That is, in this regard, the sperm may be concentrated in the collection chamber
825 to facilitate easier harvesting.
[0077] One such tool for inducing ovulation is Ovidrel
®, as disclosed in
US 5,767,251 A. This tool is biologically active heterodimeric human fertility hormones composed
of two different subunits, each subunit being synthesized in the same cell transformed
by at least one cell expression vector having heterologous DNA encoding each subunit
with each subunit being controlled by a separate promoter. Preferred human fertility
hormones include hCG, hLH and hFSH.
[0078] A system for sorting sperm is provided that includes a housing and a microfluidic
system supported by the housing. The system also includes an inlet providing access
to the microfluidic system to deliver sperm to the microfluidic system and an outlet
providing access to the microfluidic system to harvest sorted sperm from the microfluidic
system. The microfluidic system provides a flow path for sperm from the inlet to the
outlet and includes at least one channel extending from the inlet to the outlet to
allow sperm delivered to the microfluidic system through the inlet to progress along
the flow path toward the outlet. The microfluidic system also includes a filter including
a plurality of micropores and arranged in the flow path between the inlet and the
outlet to cause sperm traveling along the flow path to move against the filter and
gravity to reach the outlet.
[0079] A method for sorting sperm includes delivering a sample of sperm to an inlet connected
to a microfluidic system and allowing sperm in the sample of sperm to traverse a flow
path through the microfluidic system toward an outlet providing access to the microfluidic
system to harvest sorted sperm from the microfluidic system. The method also includes
filtering the sperm prior to reaching the outlet using a filter having a plurality
of micropores and gravity to restrict movement of the sperm through the filter. The
method further includes harvesting sperm passing to the outlet after passing through
the filter and overcoming gravity.
[0080] For the purposes of promoting and understanding of the principles of the invention,
reference has been made to the preferred embodiments illustrated in the drawings,
and specific language has been used to describe these embodiments. However, this specific
language intends no limitation of the scope of the invention, and the invention should
be construed to encompass all embodiments that would normally occur to one of ordinary
skill in the art. The particular implementations shown and described herein are illustrative
examples of the invention and are not intended to otherwise limit the scope of the
invention in any way. For the sake of brevity, conventional aspects of the system
(and components of the individual operating components of the system) may not be described
in detail. Furthermore, the connecting lines, or connectors shown in the various figures
presented are intended to represent exemplary functional relationships and/or physical
or logical couplings between the various elements. It should be noted that many alternative
or additional functional relationships, physical connections or logical connections
may be present in a practical device. Moreover, no item or component is essential
to the practice of the invention unless the element is specifically described as "essential"
or "critical." Numerous modifications and adaptations will be readily apparent to
those skilled in this art without departing from the spirit and scope of the present
invention.